Go to
JCI Insight
Citations to this article
Chinavenmeni S. Velu, … , Brian Gebelein, H. Leighton Grimes
Published December 16, 2013
Citation Information: J Clin Invest. 2014;124(1):222-236. https://doi.org/10.1172/JCI66005.
Citation Information: J Clin Invest. 2014;124(1):222-236. https://doi.org/10.1172/JCI66005.
Abstract
Acute myelogenous leukemia (AML) subtypes that result from oncogenic activation of homeobox (HOX) transcription factors are associated with poor prognosis. The HOXA9 transcription activator and growth factor independent 1 (GFI1) transcriptional repressor compete for occupancy at DNA-binding sites for the regulation of common target genes. We exploited this HOXA9 versus GFI1 antagonism to identify the genes encoding microRNA-21 and microRNA-196b as transcriptional targets of HOX-based leukemia oncoproteins. Therapeutic inhibition of microRNA-21 and microRNA-196b inhibited in vitro leukemic colony forming activity and depleted in vivo leukemia-initiating cell activity of HOX-based leukemias, which led to leukemia-free survival in a murine AML model and delayed disease onset in xenograft models. These data establish microRNA as functional effectors of endogenous HOXA9 and HOX-based leukemia oncoproteins, provide a concise in vivo platform to test RNA therapeutics, and suggest therapeutic value for microRNA antagonists in AML.
Authors
Chinavenmeni S. Velu, Aditya Chaubey, James D. Phelan, Shane R. Horman, Mark Wunderlich, Monica L. Guzman, Anil G. Jegga, Nancy J. Zeleznik-Le, Jianjun Chen, James C. Mulloy, Jose A. Cancelas, Craig T. Jordan, Bruce J. Aronow, Guido Marcucci, Balkrishen Bhat, Brian Gebelein, H. Leighton Grimes
Total citations by year
Citation information
Citations to this article (48)
| Title and authors | Publication | Year |
|---|---|---|
|
Oral Cancer-Derived miR-762 Suppresses T-Cell Infiltration and Activation by Horizontal Inhibition of CXCR3 Expression
Peng HY, Chang CW, Wu PH, Li LJ, Lin YL, Hsiao M, Chang JY, Chang PM, Lee HL, Chang WM |
International Journal of Molecular Sciences | 2025 |
|
MicroRNAs Associated with a Bad Prognosis in Acute Myeloid Leukemia and Their Impact on Macrophage Polarization
Jimbu L, Mesaros O, Joldes C, Neaga A, Zaharie L, Zdrenghea M |
Biomedicines | 2024 |
|
Nucleic acid therapeutics as differentiation agents for myeloid leukemias.
Kovecses O, Mercier FE, McKeague M |
Leukemia | 2024 |
|
miR-196b-Oct1/2 axis regulates DNMT3A-mutant AML pathogenesis.
Lawler ME, Goetz ML, Romer-Seibert JS, Gamlen HA, McGlinn E, Meyer SE |
Leukemia | 2024 |
|
Control of focal adhesion kinase activation by RUNX1-regulated miRNAs in high-risk AML.
Akhade VS, Liu T, Docking TR, Jiang J, Gopal A, Karsan A |
Leukemia | 2023 |
|
Clinical Significance of microRNAs in Hematologic Malignancies and Hematopoietic Stem Cell Transplantation
Sevcikova A, Fridrichova I, Nikolaieva N, Kalinkova L, Omelka R, Martiniakova M, Ciernikova S |
Cancers | 2023 |
|
Signaling pathways governing the behaviors of leukemia stem cells
Azizidoost S, Nasrolahi A, Sheykhi-Sabzehpoush M, Anbiyaiee A, Khoshnam SE, Farzaneh M, Uddin S |
Genes & Diseases | 2023 |
|
GFI1 Cooperates with IKZF1/IKAROS to Activate Gene Expression in T-cell Acute Lymphoblastic Leukemia
W Sun, J Guo, D McClellan, A Poeschla, D Bareyan, M Casey, B Cairns, D Tantin, M Engel |
Molecular cancer research : MCR | 2022 |
|
microRNA expression in acute myeloid leukaemia: New targets for therapy?
Fletcher D, Brown E, Javadala J, Uysal\u2010Onganer P, Guinn B |
2022 | |
|
MiR-181a and -b expression in acute lymphoblastic leukemia and its correlation with acute graft-versus-host disease after hematopoietic stem cell transplantation, COVID-19 and torque teno viruses
MI Saadi, M Ramzi, Z Hesami, N kheradmand, M Owjfard, EN Abdolyousefi, Z Karimi |
VirusDisease | 2021 |
|
Clinical and Molecular Insights in Erythropoiesis Regulation of Signal Transduction Pathways in Myelodysplastic Syndromes and β-Thalassemia
S Parisi, C Finelli, A Fazio, AD Stefano, S Mongiorgi, S Ratti, A Cappellini, AM Billi, L Cocco, MY Follo, L Manzoli |
International journal of molecular sciences | 2021 |
|
Biological Basis for Efficacy of Activin Receptor Ligand Traps in Myelodysplastic Syndromes
Amit Verma, Rajasekhar Suragani, Srinivas Aluri, Nishi Shah, Tushar D. Bhagat, Mark Alexander, Rami Komrokji, Ravindra Kumar |
Journal of Clinical Investigation | 2020 |
|
Targeting microRNA in hematologic malignancies
Z Han, ST Rosen, C Querfeld |
Current Opinion in Oncology | 2020 |
|
The microRNA miR-196b acts as a tumor suppressor in Cdx2-driven acute myeloid leukemia
VP Rawat, M Götze, A Rasalkar, NM Vegi, S Ihme, S Thoene, A Pastore, D Bararia, H Döhner, K Döhner, M Feuring-Buske, L Quintanilla-Fend, C Buske |
Haematologica | 2019 |
|
Non-coding RNAs in cancers with chromosomal rearrangements: the signatures, causes, functions and implications
C Han, LY Sun, WT Wang, YM Sun, YQ Chen, Z Wang |
Journal of Molecular Cell Biology | 2019 |
|
Heterocyclic Diamidine DNA ligands as HOXA9 Transcription Factor Inhibitors: Design, Molecular Evaluation and Cellular Consequences in HOXA9-Dependant Leukemia Cell Model
S Depauw, M Lambert, S Jambon, A Paul, P Peixoto, R Nhili, L Marongiu, M Figeac, C Dassi, C Paul-Constant, B Billoré, A Kumar, AA Farahat, MA Ismail, E Mineva, DP Sweat, CE Stephens, DW Boykin, WD Wilson, MH David-Cordonnier |
Journal of Medicinal Chemistry | 2019 |
|
Differential expression of miRNAs in acute myeloid leukemia quantified by Nextgen sequencing of whole blood samples
A Pandita, P Ramadas, A Poudel, N Saad, A Anand, A Basnet, D Wang, F Middleton, DM Gilligan, F Bertolini |
PloS one | 2019 |
|
A Case of Identity: HOX Genes in Normal and Cancer Stem Cells
Smith, Zyoud, Allegrucci |
Cancers | 2019 |
|
Improved chemotherapy modeling with RAG-based immune deficient mice
M Wunderlich, N Manning, C Sexton, A Sabulski, L Byerly, E OBrien, JP Perentesis, B Mizukawa, JC Mulloy, D Thomas |
PloS one | 2019 |
|
Turning Stem Cells Bad: Generation of Clinically Relevant Models of Human Acute Myeloid Leukemia through Gene Delivery- or Genome Editing-Based Approaches
M Mesuraca, N Amodio, E Chiarella, S Scicchitano, A Aloisio, B Codispoti, V Lucchino, Y Montalcini, H Bond, G Morrone |
Molecules (Basel, Switzerland) | 2018 |
|
MicroRNAs as New Biomarkers for Diagnosis and Prognosis, and as Potential Therapeutic Targets in Acute Myeloid Leukemia
S Trino, D Lamorte, A Caivano, I Laurenzana, D Tagliaferri, G Falco, LD Vecchio, P Musto, LD Luca |
International journal of molecular sciences | 2018 |
|
miR-196b target screen reveals mechanisms maintaining leukemia stemness with therapeutic potential
SE Meyer, DE Muench, AM Rogers, TJ Newkold, E Orr, E OBrien, JP Perentesis, JG Doench, A Lal, PJ Morris, CJ Thomas, J Lieberman, E McGlinn, BJ Aronow, N Salomonis, HL Grimes |
Journal of Experimental Medicine | 2018 |
|
Role of HOX Genes in Stem Cell Differentiation and Cancer
S Bhatlekar, JZ Fields, BM Boman |
Stem Cells International | 2018 |
|
MicroRNA, an Antisense RNA, in Sensing Myeloid Malignancies
SR Setijono, HY Kwon, SJ Song |
Frontiers in Oncology | 2018 |
|
Micro-ribonucleic acid-155 is a direct target of Meis1, but not a driver in acute myeloid leukemia
E Schneider, A Staffas, L Röhner, ED Malmberg, A Ashouri, K Krowiorz, N Pochert, C Miller, SY Wei, L Arabanian, C Buske, H Döhner, L Bullinger, L Fogelstrand, M Heuser, K Döhner, P Xiang, J Ruschmann, OI Petriv, A Heravi-Moussavi, CL Hansen, M Hirst, RK Humphries, A Rouhi, L Palmqvist, F Kuchenbauer |
Haematologica | 2017 |
|
Understanding of leukemic stem cells and their clinical implications
X Wang, S Huang, JL Chen |
Molecular Cancer | 2017 |
|
Disruption of the C/EBPα—miR-182 balance impairs granulocytic differentiation
AA Wurm, P Zjablovskaja, M Kardosova, D Gerloff, D Bräuer-Hartmann, C Katzerke, JU Hartmann, T Benoukraf, S Fricke, N Hilger, AM Müller, M Bill, S Schwind, DG Tenen, D Niederwieser, M Alberich-Jorda, G Behre |
Nature Communications | 2017 |
|
Stem and progenitor cell alterations in myelodysplastic syndromes
A Shastri, B Will, U Steidl, A Verma |
Blood | 2017 |
|
Specific Depletion of Leukemic Stem Cells: Can MicroRNAs Make the Difference?
TM Canales, D Leeuw, E Vermue, G Ossenkoppele, L Smit |
Cancers | 2017 |
|
MicroRNAs and acute myeloid leukemia: therapeutic implications and emerging concepts
JA Wallace, RM OConnell |
Blood | 2017 |
|
miR-99 regulates normal and malignant hematopoietic stem cell self-renewal
M Khalaj, CM Woolthuis, W Hu, BH Durham, SH Chu, S Qamar, SA Armstrong, CY Park |
Journal of Experimental Medicine | 2017 |
|
The biomarkers of leukemia stem cells in acute myeloid leukemia
Y Ding, H Gao, Q Zhang |
Stem Cell Investigation | 2017 |
|
S6K1 regulates Hematopoietic Stem Cell Self-Renewal and Leukemia Maintenance
Joydeep Ghosh, Michihiro Kobayashi, Baskar Ramdas, Anindya Chatterjee, Peilin Ma, Raghuveer Singh Mali, Nadia Carlesso, Yan Liu, David Plas, Rebecca J. Chan, Reuben Kapur |
Journal of Clinical Investigation | 2016 |
|
The Lupus Susceptibility Gene Pbx1 Regulates the Balance between Follicular Helper T Cell and Regulatory T Cell Differentiation
SC Choi, TE Hutchinson, AA Titov, HR Seay, S Li, TM Brusko, BP Croker, S Salek-Ardakani, L Morel |
Journal of immunology (Baltimore, Md. : 1950) | 2016 |
|
Deregulation of the HOXA9/MEIS1 axis in acute leukemia:
CT Collins, JL Hess |
Current Opinion in Hematology | 2016 |
|
Ezh2 Controls an Early Hematopoietic Program and Growth and Survival Signaling in Early T Cell Precursor Acute Lymphoblastic Leukemia
E Danis, T Yamauchi, K Echanique, X Zhang, JN Haladyna, SS Riedel, N Zhu, H Xie, SH Orkin, SA Armstrong, KM Bernt, T Neff |
Cell Reports | 2016 |
|
The miR-17∼92 cluster contributes to MLL leukemia through the repression of MEIS1 competitor PKNOX1
YA Mian, NJ Zeleznik-Le |
Leukemia Research | 2016 |
|
miR-126 Regulates Distinct Self-Renewal Outcomes in Normal and Malignant Hematopoietic Stem Cells
ER Lechman, B Gentner, SW Ng, EM Schoof, P van Galen, JA Kennedy, S Nucera, F Ciceri, KB Kaufmann, N Takayama, SM Dobson, A Trotman-Grant, G Krivdova, J Elzinga, A Mitchell, B Nilsson, KG Hermans, K Eppert, R Marke, R Isserlin, V Voisin, GD Bader, PW Zandstra, TR Golub, BL Ebert, J Lu, M Minden, JC Wang, L Naldini, JE Dick |
Cancer Cell | 2016 |
|
MiR-424 and miR-27a increase TRAIL sensitivity of acute myeloid leukemia by targeting PLAG1
Y Sun, F Lu, X Han, M Ji, Y Zhou, A Zhang, H Wang, D Ma, C Ji |
Oncotarget | 2016 |
|
Targeting leukemia stem cells in vivo with antagomiR-126 nanoparticles in acute myeloid leukemia
AM Dorrance, P Neviani, GJ Ferenchak, X Huang, D Nicolet, KS Maharry, HG Ozer, P Hoellarbauer, J Khalife, EB Hill, M Yadav, BN Bolon, RJ Lee, LJ Lee, CM Croce, R Garzon, MA Caligiuri, CD Bloomfield, G Marcucci |
Leukemia | 2015 |
|
miRNAs in acute myeloid leukemia
Q Liao, B Wang, X Li, G Jiang |
Oncotarget | 2015 |
|
Role of Hox genes in stem cell differentiation
A Seifert |
World journal of stem cells | 2015 |
|
E2F8 as a Novel Therapeutic Target for Lung Cancer
SA Park, J Platt, JW Lee, F Lopez-Giraldez, RS Herbst, JS Koo |
JNCI Journal of the National Cancer Institute | 2015 |
|
Independent regulation of vertebral number and vertebral identity by microRNA-196 paralogs
SF Wong, V Agarwal, JH Mansfield, N Denans, MG Schwartz, HM Prosser, O Pourquié, DP Bartel, CJ Tabin, E McGlinn |
Proceedings of the National Academy of Sciences | 2015 |
|
MicroRNAs in Myeloid Hematological Malignancies
M Ciccone, G Calin |
Current genomics | 2015 |
|
Two decades of leukemia oncoprotein epistasis: the MLL1 paradigm for epigenetic deregulation in leukemia
BE Li, P Ernst |
Experimental Hematology | 2014 |
|
Targeting leukemia stem cells: in vitro veritas?
Bond HM, Mesuraca M, Morrone G |
Oncotarget | 2014 |
|
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd |
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology | 2009 |
Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)